Fact CheckerSign in

NCT07625033Not yet recruiting

Risk Factors of Atrial Fibrillation After Cardiac Surgery

Source: ClinicalTrials.gov · Last updated 25 Jun 2026

Brief summary (registry, in English)

Supraventricular arrhythmias complicate more than 40% of cardiac surgeries and are associated with an increased risk of bleeding, stroke, heart failure, and death. Preventing the occurrence of these arrhythmias is a major challenge. This study aims to investigate risk factors and protective factors regarding atrial fibrillation and other iatrogenic cardiac arrhythmias after cardiac surgery, particularly innovative anesthetic strategies such as stellar ganglion blockade which have been recently implemented in our center.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
918 (estimated)
First submitted
29 May 2026
Start date
1 Jul 2026
Primary completion date
1 Jul 2026
Lead sponsor
Centre Hospitalier Régional Metz-Thionville
NCT number
NCT07625033

What you commit to

  • Study type: Observational
  • Planned participants: 918
  • From 1 Jul 2026 to the primary completion date, 1 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Atrial fibrillation at the admission in hospital.

Who the study is looking for

  • age \>18
  • having undergone a scheduled cardiac surgery in the study center
  • having agreed to the reuse of their hospital care data

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHR Metz-Thionville/Hopital de Mercy
Coordinator of this site? Confirm its status
MetzFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.